The findings could lead to genetic tests that predict the likelihood of disease recurrence in breast cancer patients and ...
“These medicines will give people more treatment options and help them to live well for longer,” says Pharmac’s Director Equity and Engagement, Dr Nicola Ngawati. “We expect about 180 people will ...
They can also rarely start in other organs of the body such as the bowel, lungs and liver. It’s a worrying time for many people and we want to be there for you whenever - and wherever - you need us.
Research indicates that microplastics can penetrate cells and induce oxidative stress. Below we list the many harmful effects ...
Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, remains committed to advancing physician education and recently supported Dr ...
Through endocrine disruption, PFAS may: harm the liver and kidney harm reproductive health cause tumors and cancer increase the risk of obesity alter cholesterol levels Individuals can become ...
Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients with gastroenteropancreatic neuroendocrine tumors, a phase 3 trial found.
Some people use Zollinger-Ellison syndrome and gastrinoma interchangeably. Learn the similarities and differences between the ...
Medically reviewed by Jamie Johnson, RDN For thousands of years, ashwagandha (Indian ginseng or winter cherry) has been used in Ayurvedic medicine—India's traditional medicine system—due to its many ...
Dr Liz O'Riordan's brilliant new book aims to challenge misinformation about cancer. In an exclusive extract, she tackles ...
During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...
HER2–negative locally advanced or metastatic breast cancer who had progressed on prior endocrine therapy (ET), compared to placebo plus fulvestrant, per phase 3 LEONARDA-1 trial (NCT05054751) findings ...